Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ribox Therapeutics Ltd.

Clinical trials sponsored by Ribox Therapeutics Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Gene therapy injection aims to cure radiation dry mouth Results expected Aug 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1

Can an RNA 'Message' reprogram the immune system to stop autoimmune blood disorders?

Disease control Not yet recruiting

This early-stage trial is testing an experimental therapy called RXIM002 in adults with relapsed or refractory autoimmune cytopenias, including immune thrombocytopenia (ITP). The therapy uses a special RNA molecule to instruct the body to produce CAR T cells that target and poten…

Phase 1 • Sponsor: RiboX Therapeutics Ltd. • Aim: Disease control

Last updated Aug 29, 2026 00:00 UTC